Insulin signaling in health and disease
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms of cellular insulin action have been the focus of much investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in metabolic syndrome, a condition known as insulin resistance. The actions of the hormone are initiated by binding to its receptor on the surface of target cells. The receptor is an α2β2 heterodimer that binds to insulin with high affinity, resulting in the activation of its tyrosine kinase activity. Once activated, the receptor can phosphorylate a number of intracellular substrates that initiate discrete signaling pathways. The tyrosine phosphorylation of some substrates activates phosphatidylinositol-3-kinase (PI3K), which produces polyphosphoinositides that interact with protein kinases, leading to activation of the kinase Akt. Phosphorylation of Shc leads to activation of the Ras/MAP kinase pathway. Phosphorylation of SH2B2 and of Cbl initiates activation of G proteins such as TC10. Activation of Akt and other protein kinases produces phosphorylation of a variety of substrates, including transcription factors, GTPase-activating proteins, and other kinases that control key metabolic events. Among the cellular processes controlled by insulin are vesicle trafficking, activities of metabolic enzymes, transcriptional factors, and degradation of insulin itself. Together these complex processes are coordinated to ensure glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–210 of 210
Sano, H., Peck, G. R., Blachon, S., & Lienhard, G. E. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.069 · Cited by 35 · cited 1×
“Once activated, TC10 binds to the exocyst scaffolding subunit Exo70, which assembles the complex at the plasma membrane (135, 136, 138, 139).”
BackgroundInsulin Activation of Plasma Nonesterified Fatty Acid Uptake in Metabolic Syndrome
Ramos-Roman, M. A., Lapidot, S. A., Phair, R. D., & Parks, E. J. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.250019 · Cited by 32 · cited 1×
“In addition to suppressing lipolysis, insulin stimulates fatty acid uptake (145).”
BackgroundChen, Q., Rong, P., Zhu, S., Yang, X., Ouyang, Q., Wang, H. Y., & Chen, S. (2019) · Science Advances · doi:10.1126/sciadv.aav4116 · Cited by 30 · cited 2×
“1172/JCI142241 leads to RalA activation in both adipocytes (141) and muscle (142), along with a dramatic increase in glucose uptake and improved glucose tolerance (142).”
BackgroundMolecular Defects in Insulin Action
Kahn, C. R., & Goldstein, B. J. (1989) · Science · doi:10.1126/science.2662406 · Cited by 25
Insulin receptor internalization and recycling: mechanism and significance
Carpentier, J. L., Fehlmann, M., OBBERGHEN, E. V., Görden, P., & Orci, L. (1985) · Biochimie · doi:10.1016/s0300-9084(85)80112-7 · Cited by 25
Post-translational processing and activation of insulin and EGF proreceptors
Lane, M. D., Ronnett, G. V., Slieker, L. J., Kohanski, R. A., & Olson, T. L. (1985) · Biochimie · doi:10.1016/s0300-9084(85)80104-8 · Cited by 24 · cited 1×
“The receptor’s two subunits derive from a single precursor processed by a furin-like enzyme to produce an α/β subunit complex, which then undergoes disulfide linkage to form the tetramer (8, 10, 11).”
BackgroundYamada, K. D., Carpentier, J., Cheatham, B., Gonçalves, E., Shoelson, S. E., & Kahn, C. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3115 · Cited by 23
Spatial Compartmentalization in the Regulation of Glucose Metabolism by Insulin
Brady, M., Pessin, J. E., & Saltiel, A. R. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00201-5 · Cited by 21
Self-citationLongo, N., Langley, S. D., Griffin, L. D., & Elsas, L. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7538143 · Cited by 19 · cited 1×
“These recessive conditions are characterized by restricted intrauterine and postnatal growth, dysmorphic features, altered glucose homeostasis, and early death (28, 29).”
BackgroundYamamoto, R., Shiba, T., Tobe, K., Shibasaki, Y., Koshio, O., Izumi, T., Odawara, M., Mikami, Y., Matsuura, N., Akanuma, Y., et al. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-869 · Cited by 14
Research works printed but not linked: 2
- Kido, 2001, Clinical review 125: The insulin receptor and its cellular targets, J Clin Endocrinol Metab, 86, 972
- O-Sullivan, 2015, FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization, Nat Commun, 6
Cited by
Exosomes as mediators of intercellular crosstalk in metabolism
Isaac, R., Reis, F. C. G., Ying, W., & Olefsky, J. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.006 · Cited by 820
Mechanisms of Oxidative Stress in Metabolic Syndrome
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097898 · Cited by 717
Role of Insulin in Health and Disease: An Update
Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126403 · Cited by 472
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Metadata
- Authors
- Saltiel, A. R.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Saltiel, Alan R.
- ORCID
- Saltiel, Alan R.
- Venue
- Journal of Clinical Investigation
- Published
- 2021-01-04
- Volume
- 131
- Issue
- 1
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7773347
- OpenAlex
- W3119743465
- Cited by
- 446
- References
- 210
- Citations by year
- 2026: 63 · 2025: 113 · 2024: 84 · 2023: 92 · 2022: 72 · 2021: 22
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124496, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin signaling, insulin resistance, metabolic syndrome, insulin receptor, tyrosine kinase, PI3K/Akt signaling, CBL, TC10, glucose homeostasis, vesicle trafficking, insulin degradation, transcription factors, GTPase-activating protein
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Receptor, Insulin, Phosphatidylinositol 3-Kinases, MAP Kinase Signaling System, Metabolic Syndrome, History, 20th Century, History, 21st Century, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.